期刊文献+

时辰诱导化疗序贯同步放化疗治疗局部晚期头颈部鳞癌的临床疗效观察 被引量:9

Clinical observation of induction chrono- chemotherapy followed by concurrent chemoradiation in patients with local advanced head and neck squamous cell carcinoma
下载PDF
导出
摘要 目的:观察时辰诱导化疗序贯同步放化疗治疗局部晚期头颈部鳞癌的近期疗效、毒副反应。方法:对50例不可切除的局部晚期头颈部鳞癌先给予2-3周期TPF时辰诱导化疗,多西他赛75mg/m2,顺铂75mg/m2,分5天完成,静滴给药,每天10∶00-22∶00;5-氟尿嘧啶750mg/(m2·d),第1-5天,持续静滴,每天22∶00-10∶00,21天为1周期,然后调强放疗(IMRT),顺铂80mg/m2,3周重复同期化疗,治疗结束后评价疗效及毒副反应,并统计2年生存率。结果:50例均可评价疗效,其中CR 19例,PR 12例,SD 11例,PD 8例,总有效率(CR+PR)62.0%,疾病控制率(CR+PR+SD)84.0%。2年总生存率58.0%。结论:时辰诱导化疗后序贯同步放化疗治疗局部晚期头颈部鳞癌临床疗效较好,毒副反应可耐受。 Objective:To study the efficacy and toxicities of induction chrono-chemotherapy followed by concur-rent chemoradiation in local advanced head and neck squamous cell carcinoma. Methods:Fifty patients with unresect-ed locally advanced head and neck squamous cell carcinoma were treated with induction chrono-chemotherapy of two or three cycles regimen. The TPF chemotherapy regimen was administered as follows:TXT 75mg/m2;DDP 75mg/m2 , bolus infusion from 10:00 to 22:00,d1-5 ,and 5-FU 750mg/( m2 ·d)bolus infusion from 22:00 to 10:00,d1-5 , with 21 days each cycle,followed by concomitant intensity - modulated radiotherapy( IMRT ) and chemotherapy (DDP 80mg/m2,with 3 weeks each cycle). The efficacy,toxicities and 2 years overall survival were reviewed after treatment. Results:All 50 patients were evaluated for response,CR 19 cases,PR 12 cases,SD 11 cases,PD 8 cases. The total efficiency was 62. 0%,the disease control rate was 84. 0% and 2 years overall survival rate was 58. 0%. Conclusion:Chrono-chemotherapy followed by concurrent chemoradiation is effective in the treatment of patients with locally advanced head and neck squamous cell carcinoma,and the toxicities are tolerable.
出处 《现代肿瘤医学》 CAS 2014年第6期1301-1304,共4页 Journal of Modern Oncology
关键词 局部晚期头颈部鳞癌 时辰诱导化疗 调强放射治疗 同步放化疗 local advanced head and neck squamous cell carcinoma chrono-chemotherapy intensity-modulated radiotherapy(IMRT) concurrent chemoradiation
  • 相关文献

参考文献3

二级参考文献39

  • 1郭灵,林焕新,邱枋,孙蕊,罗东华,洪明晃,冼励坚,F.LEVY.5-FU与DDP时间调节化疗治疗晚期鼻咽癌的初步临床观察[J].中国肿瘤临床,2004,31(13):721-724. 被引量:15
  • 2金风,欧阳金陵,董红敏,吴伟莉,陈海霞,何志惠.鼻咽癌DDP+5-FU/CF方案时辰化疗的临床前瞻性随机研究[J].中国肿瘤临床,2004,31(19):1123-1125. 被引量:25
  • 3王雅平,华鲁纯,张延龄.生物钟基因与肿瘤[J].国际外科学杂志,2006,33(4):279-283. 被引量:6
  • 4King DP,Takaheshi JS. Molecular genetics of circadian rhythms in mammals[ J ]. Annu Rev Neurosci ,2000,23 (7) :713 - 742.
  • 5Dunlap JC. Molecular base for circadian[ J. Cell, 1999,96 (2) : 271 - 290.
  • 6Shigehiro OHDO. Chronopharmaceutics:pharmaceutics focused on biological rhythm [ J ] Biol Pharm Bu11,2010,33 (2) : 159 - 167.
  • 7Lee CC. Tumor suppression and circadian function [ J ]. J Biol Rhythms ,2007,22:291 - 298.
  • 8Chen ST, Choo KB, Hou MF, et al. Deregulated expression of the Perl, Per2 and Per3 gene in breast cancer [ M ]. Oxford University Press ,2005 : 1241 - 1246.
  • 9Yeh KT , Yang MY, Liu TC , et al. Abnormal expression of period 1 ( PER1 ) in endometrial carcinoma[ J ]. J Pathol, 2005,206 : 111 - 120.
  • 10Lin YM, Chang JH, Yeh KT, et al. Disturbance of circadian gene expression in hepatocellular carcinoma [ J ]. Mol Carcinogenesis, 2008,47(12) :925 -933.

共引文献131

同被引文献95

引证文献9

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部